Overall Status

Completed (2)

Recruiting (1)

Unknown status (1)

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Janssen Pharmaceutical K.K. (1)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)

Novartis Pharmaceuticals (1)

University of Zurich (1)

Collaborator

Intervention

anakinra (1)

collection of biological samples (1)

cosentyx (1)

guselkumab (1)

Study Documents

Intervention Type

drug (2)

other (1)

procedure (1)

Funder Type

Industry (2)

NIH (1)

Other (1)

Study Type

Interventional (2)

Observational (2)

pustular psoriasis

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Evaluate Safety and Efficacy of Cosentyx in Pediatric PsV, PsA,

Recruiting

Psoriasis Vulgaris
+2 more

Cosentyx

Nagoya-city, Aichi, Japan
+23 more

Aug 3, 2022

Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau, Pustular Psoriasis Trial run by the NIAMS (Anakinra)

Completed

Has Results

Sneddon-Wilkinson
+3 more

Anakinra

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Apr 5, 2021

Pustular Psoriasis Trial in Japan (Guselkumab)

Completed

Pustular Psoriasis

Guselkumab

Asahikawa, Japan
+19 more

Oct 22, 2019

Genetic Architecture of Neutrophil-Mediated Inflammatory Skin

Unknown status

Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue
+27 more

Collection of biological samples

Zurich, ZH, Switzerland

University Hospital Zurich, Dept. of Dermatology

Sep 26, 2016